Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Rep. Walkinshaw on 3 Tech Priorities: TMF, FITARA and FedRAMP
The congressman discussed major federal technology developments and where policy can impact IT modernization and workforce development.
15m watch -
DOE's AI-FORTS Program Tackles Cybersecurity in Energy Infrastructure
AI and industry partnerships are helping improve threat detection and strengthen cybersecurity across the energy sector.
4m read -
NIST's New Security Controls Address Agents in Software Development
NIST is exploring identity management, least-privilege access and human oversight to secure autonomous AI agents in development workflows.
4m read -
HHS Looks to AI, Innovation to Advance Women’s Healthcare
HRSA’s new $1 million initiative aims to modernize women’s preventive care guidelines, expand access to care and advance women’s health.
2m read
